ArticleScientific reports2026
Integrated microfluidic device for DNA extraction using electric valves.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Deoxyribonucleic acid (DNA) encodes the genetic instructions that govern the development and function of living organisms, and its isolation is a critical prerequisite for downstream applications such as sequencing and diagnostic assays. Here, we present an integrated lab-on-a-chip platform that automates genomic DNA extraction by combining a passive micromixer for chemical cell lysis with a silica-based filtration unit. The system comprises three microfluidic chips for mixing, lysis, and purification, interconnected by electrically actuated valves to precisely route fluids through each stage. We systematically optimized key parameters fluid velocity, filter thickness, lysis temperature, and cell concentration, and identified the ideal operating conditions: 2.5 × 10⁶ cells/mL input, 65 °C lysis, a single silica filter, and a 25 mL vacuum chamber to drive flow. Under these settings, the device delivered 147.23 ± 29.04 ng/µL DNA, corresponding to approximately 90% extraction efficiency relative to a commercial silica-column kit. Finally, we confirmed the integrity of the recovered DNA by PCR amplification and agarose-gel electrophoresis on seven representative samples. These results demonstrate that our multi-chip microfluidic platform provides rapid, efficient, and semi-automated genomic DNA isolation, offering a robust alternative to conventional bench-top methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.